Bioscript Group
James Maxwell currently serves as the Chief Financial Officer at Bioscript Group, a position held since September 2023. Prior to this role, James Maxwell was the Chief Financial Officer at Panthera Biopartners from September 2022 to September 2023. Earlier in their career, James Maxwell held the position of Managing Director and Chief Operating Officer at CHS Healthcare from February 2018 to September 2022. James Maxwell's experience at KPMG spanned from September 2008 to February 2018, where James Maxwell progressed from an Associate in KPMG Corporate Finance to an Associate Director.
Bioscript Group
Established in 2005, Bioscript Group is formed from multiple, specialist businesses to support our global pharmaceutical clients; we draw on their multidisciplinary expertise to help navigate critical decisions at key points in the product lifecycle. Our scientific and strategic expertise help our clients make better decisions. We provide medical communication services, market access consulting and regulatory writing support with deep domain expertise to effectively navigate complex disease areas.